Filing Flows › Comparisons › PGNY vs VMD
Progyny vs Viemed Healthcare: PGNY and VMD compared
Progyny is the larger company: $341M of revenue in its latest quarter (Q3 2026) against $80.7M for Viemed Healthcare (Q3 2026). Viemed Healthcare is growing faster (+12% against +9% a year earlier). Progyny is more profitable, with an operating margin of 10.3% against 8.6%.
Where the money goes: PGNY and VMD
Progyny (PGNY) · Q3 2026
Progyny, Q3 2026: revenue $341M (+9% year over year), operating margin 10.3%, net earnings $26.3M, operating cash flow $56.6M. The chart follows the revenue to costs, profit and cash.
Viemed Healthcare (VMD) · Q3 2026
Viemed Healthcare, Q3 2026: revenue $80.7M (+12% year over year), operating margin 8.6%, net earnings $4.6M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.
| Progyny (PGNY) | Viemed Healthcare (VMD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $341M | $80.7M |
| Revenue growth, Y/Y | +9% | +12% |
| Gross margin | 24.5% | 57.3% |
| Operating margin | 10.3% | 8.6% |
| Net earnings | $26.3M | $4.6M |
| Net margin | 7.7% | 5.7% |
| Operating cash flow | $56.6M | $11.5M |
| Free cash flow | $47.2M | $4.0M |
| Market value | $2.8B | — |
| P/E | 31.1× | — |
| Analysts’ mean target | $34.83 | — |
Where the revenue comes from
Progyny
- Fertility benefits services revenue: $223M (65%)
- Pharmacy benefits services revenue: $118M (35%)
Questions
Which is bigger, Progyny or Viemed Healthcare?
Progyny is the larger company: $341M of revenue in its latest quarter (Q3 2026) against $80.7M for Viemed Healthcare (Q3 2026).
Is Progyny or Viemed Healthcare growing faster?
Viemed Healthcare is growing faster (+12% against +9% a year earlier).
Which is more profitable, Progyny or Viemed Healthcare?
Progyny is more profitable, with an operating margin of 10.3% against 8.6%.
More: Progyny earnings · how Progyny makes money · Viemed Healthcare earnings · how Viemed Healthcare makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.